Citation Impact
Citing Papers
High-throughput characterization of protein–protein interactions by reprogramming yeast mating
2017 StandoutNobel
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Biosynthesis of fluopsin C, a copper-containing antibiotic from Pseudomonas aeruginosa
2021 Science
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
2003 StandoutNobel
Formylglycine-generating enzyme binds substrate directly at a mononuclear Cu(I) center to initiate O 2 activation
2019 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
The Basic Principles of Chimeric Antigen Receptor Design
2013
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
2010 Science
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Immunotherapy of cancer in 2012
2012
Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity
2001
Finishing the euchromatic sequence of the human genome
2004 StandoutNature
Combinatorial Cancer Immunotherapy
2006
Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokers
2002
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation and cancer
2002 StandoutNature
Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients
2003
Autoantibodies Against Cancer Antigens
2009
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
2006
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Cofactor-independent oxidases and oxygenases
2010
The SSX gene family: Characterization of 9 complete genes
2002
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
2001
Identification of cancer/testis genes by database mining and mRNA expression analysis
2002
Identification and Characterization of a Novel Cancer/Testis Antigen Gene CAGE
2002
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Immunogenicity of induced pluripotent stem cells
2011 StandoutNature
Towards patient‐specific tumor antigen selection for vaccination
2002
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
2002
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Tumor‐specific shared antigenic peptides recognized by human T cells
2002
The impact of T‐cell immunity on ovarian cancer outcomes
2008
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9
2000
Immunity, Inflammation, and Cancer
2010 Standout
Identification of specific autoantigens in Sjögren's syndrome by SEREX
2005
Human tumor antigens for cancer vaccine development
1999
Serological identification of breast cancer-related antigens from aSaccharomyces cerevisiae surface display library
2005
In vivo antigen delivery by aSalmonella typhimurium type III secretion system for therapeutic cancer vaccines
2006
Cytokines in cancer pathogenesis and cancer therapy
2004
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Cancer immunotherapy comes of age
2011 StandoutNature
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Immunotherapy: past, present and future
2003
Origin and physiological roles of inflammation
2008 StandoutNature
Spinning molecular immunology into successful immunotherapy
2002
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives
2017
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Expression of cancer/testis (CT) antigens in lung cancer
2003
A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
1999
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing
2002
Identification of human tumor antigens and its implications for diagnosis and treatment of cancer
2004
BI-1 Regulates an Apoptosis Pathway Linked to Endoplasmic Reticulum Stress
2004 StandoutNobel
Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events
1999
Cancer-related inflammation
2008 StandoutNature
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Role of the conserved oligomeric Golgi (COG) complex in protein glycosylation
2008
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
2000
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Identification of a new MAGE gene with tumor-specific expression by representational difference analysis.
1998
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Lassa virus entry requires a trigger-induced receptor switch
2014 Science
The Three Es of Cancer Immunoediting
2004 Standout
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
1997
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Identification on a human sarcoma of two new genes with tumor-specific expression.
2000
Analysis of the B‐cell repertoire against antigens expressed by human neoplasms
2002
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis Antigen
2000
Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction
2003
Identification of CT46/HORMAD1, an immunogenic cancer/testis antigen encoding a putative meiosis-related protein.
2005
Large Scale Identification of Human Hepatocellular Carcinoma-Associated Antigens by Autoantibodies
2002
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Influence of CD4+CD25+ Regulatory T Cells on Low/High-Avidity CD4+ T Cells following Peptide Vaccination
2006
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.
2003
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
1998
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer.
2002
Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library
1998
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
2005 StandoutNobel
Immunomic analysis of human sarcoma
2003
Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells
2005 Standout
CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis
2000
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
CD4+CD25+T cells responding to serologically defined autoantigens suppress antitumor immune responses
2003
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia
2013
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens
1998
Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
2004
Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning
2004
The cancer/testis genes: review, standardization, and commentary.
2004
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Autoantibodies frequently detected in patients with aplastic anemia
2003
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
1998
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen
2001
Serological analysis of human tumor antigens: molecular definition and implications
1997
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Serological detection of cutaneous T-cell lymphoma-associated antigens
2001
Immune recognition and tumor protection
2002
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Works of Frank Stenner being referenced
Rational development of high-affinity T-cell receptor-like antibodies
2009
Characterization of the human GARP (Golgi associated retrograde protein) complex
2005
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes
2006
Structure of the Chlamydia Protein CADD Reveals a Redox Enzyme That Modulates Host Cell Apoptosis
2004
CADD, a Chlamydia Protein That Interacts with Death Receptors
2002
Crystal structure of PqqC from Klebsiella pneumoniae at 2.1 Å resolution
2004
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
2017
Expression and Potential Role of Fas-Associated Phosphatase-1 in Ovarian Cancer
2001
Definition of tumor-associated antigens in hepatocellular carcinoma.
2000
Human neoplasms elicit multiple specific immune responses in the autologous host.
1995
The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.
1996
BAG1 Over‐expression in Brain Protects Against Stroke
2003